Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Fesarius Therapeutics logo — A cutting-edge NY-based biotech start-up on a mission to rev...

Fesarius Therapeutics

A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine.

Founded 2015 United States United States 8 employees Grant Total: $2.63M Biotechnology, Manufacturing

General Information

Company Name Fesarius Therapeutics
Founded Year 2015
Location United States United States
Employees 8
Industries Biotechnology, Manufacturing
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Fesarius Therapeutics. To contact Fesarius Therapeutics, visit fesariustherapeutics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Fesarius Therapeutics compare?

A PDF of Fesarius Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Fesarius Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Fesarius Therapeutics

FesariusTherapeutics is a cutting-edge NY-based biotech start-up founded in 2015 with a mission to revolutionize the world of regenerative medicine. Their slogan, "A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine," reflects their dedication to innovation. The company focuses on developing innovative tissue-engineered products to transform reconstructive and aesthetic surgery. FesariusTherapeutics' flagship product, DermiSphere, is a revolutionary dermal regeneration template (DRT) for the management of wounds, based on technology spun-out from The Laboratory for Bioregenerative Medicine and Surgery at Weill Cornell Medicine. Their recent last investment of $800.00K Grant came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on 16th August 2023. This NY-based start-up operates within the Biotechnology and Manufacturing industries, solidifying its position as a pioneer in the field of regenerative medicine. With a focus on innovative technology and strong financial backing, FesariusTherapeutics is poised for significant growth and impact in the biotech space.

Business keywords: Regenerative Medicine, Tissue Engineering, Dermal Regeneration, Wound Healing, Material Science, Skin Replacement, Dermatology, Start-up, Technology Innovation, Bioregenerative Medicine, Weill Cornell Medicine, Surgical Innovation, Research and Development

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $800.00K 1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
16 Aug 2023
Grant $1.83M 1
National Institutes of Health
08 Aug 2023
Seed Round Undisclosed 1
New York Ventures
11 Apr 2022

Fesarius Therapeutics Alternatives & Competitors

View All Alternatives
Fesarius Therapeutics vs
SANUWAVE
SANUWAVE United States

Heal Wounds With Energy First

Post-IPO Equity
54 employees
Biotechnology, Health Care
Fesarius Therapeutics vs
Grandhope Biotech Co., Ltd.
Grandhope Biotech Co., Ltd. China

Pioneering biotech solutions to restore and enhance tissue and organ health.

Venture round
2 employees
Biotechnology, Manufacturing
Fesarius Therapeutics vs
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA United States

Manufacturing the Future of Biofabrication

Grant
99 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Fesarius Therapeutics

A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine.
Fesarius Therapeutics was founded in 2015.
Fesarius Therapeutics is headquartered in United States.
Fesarius Therapeutics operates in Biotechnology and Manufacturing. Its work centres on Regenerative Medicine, Tissue Engineering, Dermal Regeneration and Wound Healing.
Fesarius Therapeutics has approximately 8 employees.
Fesarius Therapeutics has completed 3 funding rounds, raising a total of $2.63M. The latest funding stage is Grant.
Top alternatives and competitors to Fesarius Therapeutics include SANUWAVE, Grandhope Biotech Co., Ltd., Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA, REGEMAT 3D, Volumina Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Fesarius Therapeutics and SANUWAVE are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Fesarius Therapeutics, https://bouncewatch.com/company/fesariustherapeutics, updated 29 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout